HARPAGOPHYTON FORTE 1450 MG
Food supplement declared in France, declaration No 2018-4-1096, decision dated 25 April 2018
HARPAGOPHYTON FORTE 1450 MG (RELAFIT) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Harpagophytum procumbens 247 mg per day, Harpagophytum procumbens 215 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- RELAFIT
- Food business operator placing the product on the market
- LABORATORIOS MORALES SOLER, S.L.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 CAPSULE
- Directions for use
- PRENDRE 1 CAPSULE PAR JOUR
- Not recommended (according to the manufacturer)
- Ulcer (stomach or duodenum)
Declaration 262355, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Extrait sec aqueux | 247 mg |
| Harpagophytum procumbens | Racine | Poudre (de plantes séchées ou broyées) | 215 mg |
Additives
E470b
Other ingredients
gélatine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
VOIR ETIQUETAGE POUR VOIR LES AVERTISSEMENTS
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : RELAFIT
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “HARPAGOPHYTON FORTE 1450 MG (RELAFIT): composition and regulation”, https://compoatlas.com/en/supplements/products/262355-harpagophyton-forte-1450-mg, updated 15 November 2026.